Navigation Links
Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
Date:6/13/2013

acts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "expects," "plans," "intends," "estimates," "potential," or "continue," or similar terms or the negative of these terms. Although CBMG believes the expectations reflected in the forward-looking statements are reasonable, they cannot guarantee that future results, levels of activity, performance or achievements will be obtained. CBMG does not have any obligation to update these forward-looking statements other than as required by law.

Contact:
Jeff Ramson 
Investor Relations
ProActive Capital Group
+1 646-863-6341

Sarah Kelly 
Director of Corporate Communications, CBMG
+1 650 566 5064
sarah.kelly@cellbiomedgroup.com


'/>"/>
SOURCE Cellular Biomedicine Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cellular Therapy and Cord Blood 2013 Market Report
2. Cellular Biomedicine Group Announces Appointment of Corporate Controller
3. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
4. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
5. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
6. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
7. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
8. Exit discovered in cellular garbage truck
9. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
10. Cellular Biomedicine Group Provides Update and 2013 Milestones
11. Unique Extracellular Matrix Used in Patient Successfully Treated for Flesh Eating Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... The ALS Therapy Development Institute ... subsidiary, Anelixis Therapeutics , $1.5 million toward the ... the innate immune system. The funding comes from the ... the 2014 social media phenomenon known as the “ALS ... raised directly by the Institute through last year’s Ice ...
(Date:5/27/2015)... 2015  Ceres, Inc. (Nasdaq: CERE ), an ... for a genetic sequence derived from soybean, covering uses ... development and plant transformation. The company believes that its ... are the target of a class of commercial herbicides. ... license to the innovation, including an opportunity for exclusivity ...
(Date:5/26/2015)... BELLINGHAM, Washington, USA (PRWEB) May 26, 2015 ... a formal partnership with the Max Planck Society ... Extreme and Quantum Photonics. The center will link two ... of photonics, and will be only the third Max ... SPIE, the international society for optics and photonics, ...
(Date:5/26/2015)... Germany , May 26, 2015 ... QGEN ; Frankfurt Prime Standard: QIA) today announced ... ® (QCI™) bioinformatics content and software platform ... on genomic variants identified in next-generation sequencing (NGS). ... platform are in oncology, for somatic and hereditary ...
Breaking Biology Technology:Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3Ceres Awarded Patent for Innovation in Soybean 2Ceres Awarded Patent for Innovation in Soybean 3Third Max Planck Centre in North America Inaugurated at University of Ottawa 2Third Max Planck Centre in North America Inaugurated at University of Ottawa 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
... and CEO -, DALLAS, Dec. 26 Access ... Chairman Jeffrey B.,Davis has been appointed to the additional ... and CEO of the Company for health reasons. Mr.,Seiler ... "I believe that Access has an exciting future with ...
... N.J., Dec. 24 Genta,Incorporated (Nasdaq: GNTA ) ... Listing Qualifications Staff of The NASDAQ Stock Market,that it ... a minimum closing bid price of $1.00 per share. ... June 16, 2008 to regain,compliance, which requires a closing ...
... 24 Wyeth,Pharmaceuticals, a division of Wyeth (NYSE: ... patent infringement claim for lost profits and other ... launch of a,pantoprazole tablet -- a generic version ... that its product infringes the United States,PROTONIX compound ...
Cached Biology Technology:Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 2Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO 3Genta Receives NASDAQ Non-Compliance Notice 2Genta Receives NASDAQ Non-Compliance Notice 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 2Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 3Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals' Launch of Generic Pantoprazole in Violation of PROTONIX Patent 4
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/19/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Global Genetic Testing Market Outlook 2018 2
... It makes me sad when an article that should have ... of the student's group in the iGEM competition , check ... their bacterial 'camera'. , Using Petri dishes full of ... The University of Texas at Austin and UCSF successfully created ...
... at the Albert Einstein College of Medicine and the ... is targeted to certain regions of a cell--a process ... wound healing and cancer metastasis. Their study appears in ... Led by Drs. Robert Singer and Dr Stefan Huettelmaier, ...
... researchers has discovered that human embryonic stem cell lines accumulate ... findings do not limit the utility of the cells for ... the researchers say, but draw attention to the need to ... study how these alterations affect the cells' behavior. The researchers' ...
Cached Biology News:Student scientists create living bacterial photographs 2Student scientists create living bacterial photographs 3Einstein scientists discover how protein crucial for motion is synthesised at the right place in the cell 2Embryonic stem cells accrue genetic changes 2Embryonic stem cells accrue genetic changes 3Embryonic stem cells accrue genetic changes 4
... SilverQuest Silver Staining Kit is uniquely ... sensitivity with minimal protein modification for ... spectrometry problems associated with traditional silver ... kit because the reagents used do ...
... formuatled for the growth of insect ... cells. Grace's Insect Mediu, Unsupplemented is ... not contain lactalbumin hydrosylate, and yeastolate, ... Insect Medium, Supplemented is formulated for ...
D.R. Harper and C. Grose (1994) • Includes: virus structure & replication, fundamental virology, immunology and pathogenesis, vaccines and antiviral drugs, novel diagnostic techniques, cloning a...
...
Biology Products: